Rybelsus, the first oral GLP-1 receptor agonist to gain approval, plays a crucial role in reshaping how individuals approach weight loss. This medication primarily works by mimicking the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). By enhancing insulin secretion in response to meals while simultaneously reducing insulin resistance,…